Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy

BACKGROUND: To evaluate spot-scanning proton arc therapy (SPArc) and multi-field robust optimized intensity modulated proton therapy (RO-IMPT) in treating stage III non-small-cell lung cancer (NSCLC) patients. METHODS: Two groups of stage IIIA or IIIB NSCLC patients (group 1: eight patients with tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoqiang, Kabolizadeh, Peyman, Yan, Di, Qin, An, Zhou, Jun, Hong, Ye, Guerrero, Thomas, Grills, Inga, Stevens, Craig, Ding, Xuanfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389253/
https://www.ncbi.nlm.nih.gov/pubmed/29486782
http://dx.doi.org/10.1186/s13014-018-0981-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389253/
https://www.ncbi.nlm.nih.gov/pubmed/29486782
http://dx.doi.org/10.1186/s13014-018-0981-6

Ejemplares similares